Dementia drugs may increase death risks [side effect = death]

[Guest guest]

SSRI-Research@

Sun, 18 Dec 2005 09:59:30 -0500

[sSRI-Research] Dementia drugs may increase death risks [side

effect = death]

 

 

 

[-- talk about insanity...]

 

 

Dementia drugs may increase death risks

Anti-psychotic medications often used to treat elderly patients

 

http://www.msnbc.msn.com/id/9742015/from/RL.5/#storyContinued

 

Updated: 4:08 p.m. ET Oct. 18, 2005

 

CHICAGO - Drugs often used to treat elderly patients with

dementia-related aggression and delusions can raise their risk of

death, according to a study that reinforces new warning labels

required on the medications.

 

The researchers pooled results of 15 previous studies on drugs known

as atypical anti-psychotics and sold under the brand names Zyprexa,

Risperdal, Seroquel and Abilify.

 

Among more than 5,000 elderly dementia patients, those taking any of

the drugs faced a 54 percent increased risk of dying within 12 weeks

of starting the medication, compared with patients taking dummy pills.

 

There were 118 deaths among the 3,353 drug users versus 40 in the

1,757-patient placebo group, or 3.5 percent compared with 2.3 percent.

The risks were similar for each of the drugs.

 

The drugs are approved for treating schizophrenia and bipolar disease,

not elderly dementia. But because schizophrenia-like symptoms are

common in elderly patients with Alzheimer's disease or other dementia,

doctors frequently prescribe the drugs to these patients, too. Such

" off-label " uses are legal.

 

The study gave no information on the causes of death, but the Food and

Drug Administration warned in April that the drugs have been linked to

deaths from heart failure and pneumonia in elderly dementia patients.

At the FDA's request, manufacturers recently revised their drug labels

to include strong warnings of the increased risk of death.

 

Dr. Lon Schneider, a University of Southern California psychiatrist

and the study's lead author, said the results should instill caution

" but not a great sense of fear. "

 

" These drugs are clinically needed and there are actually few

alternatives " for elderly dementia patients, Schneider said.

 

Withholding the drugs from patients who need them could also prove

dangerous, by increasing the chances they might harm themselves and

others, he said.

 

The study appears in Wednesday's Journal of the American Medical

Association.

 

Dr. Ronald Landbloom of Zyprexa maker Eli Lilly & Co. said the drugs

" can be very helpful with aggressive psychotic patients who are

beating up caregivers and nursing home staff, and hurting themselves, "

but doctors need to be aware of the risks.

 

William Thies, scientific director of the Alzheimer's Association,

said up to about half of all Alzheimer's patients develop problems the

drugs can treat.

 

" The trade-off is clearly going to be this small risk, " and for some

patients, the risk is worth taking, Thies said.

 

© 2005 The Associated Press. All rights reserved. This material may

not be published, broadcast, rewritten or redistributed